ArticleOncoTargets and therapy2026

A Novel Strategy for Treating Elderly Patients with Advanced Non-Small Cell Lung Cancer: Exploring the Efficacy and Safety of Anlotinib Combined with PD-1/PD-L1 Inhibitors.

Chuanzhen Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.